fig3

Extended cycles of adjuvant temozolomide improves survival outcomes in glioblastoma: a retrospective analysis

Figure 3. OS (A) and PFS (B) of patients with MGMT promoter methylation in different treatment groups.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/